Eyecare1 year ago
Harrow Acquires U.S. and Canadian Commercial Rights to VEVYE (Cyclosporine Ophthalmic Solution) 0.1% from Novaliq
VEVYE is the first and only cyclosporine-based product indicated for the treatment of both signs and symptoms of dry eye disease with efficacy demonstrated after four...